In experimental and human T2DM, the responsiveness of the myocardium to β-AR stimulation and AC stimulating effects of β-AR agonists was, as a rule, decreased, and, unlike in T1DM, the number of β-ARs did not differ significantly from control [41, 130–132]. This evidence concerns the gene CTBP1 and type 1 diabetes mellitus.